The University of Chicago Header Logo

Connection

Linda Wagner-Weiner to Adolescent

Back to Details
This is a "connection" page, showing publications Linda Wagner-Weiner has written about Adolescent.
Linda Wagner-Weiner
Connection Strength
0.417
Adolescent
  1. Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis. Pediatr Rheumatol Online J. 2021 Jun 05; 19(1):81.
    View in: PubMed
    Score: 0.082
  2. Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy. Pediatr Rheumatol Online J. 2019 Feb 18; 17(1):8.
    View in: PubMed
    Score: 0.070
  3. Demystifying the Positive Antinuclear Antibody Test in Children: A Clinical Review. Pediatr Ann. 2015 Jun; 44(6):e131-5.
    View in: PubMed
    Score: 0.054
  4. Pediatric rheumatology for the adult rheumatologist. J Clin Rheumatol. 2008 Apr; 14(2):109-19.
    View in: PubMed
    Score: 0.033
  5. Adherence to medication by adolescents and young adults with childhood-onset systemic lupus erythematosus. Lupus. 2022 Oct; 31(12):1508-1515.
    View in: PubMed
    Score: 0.022
  6. Epstein-Barr virus burden in adolescents with systemic lupus erythematosus. Pediatr Infect Dis J. 2001 Feb; 20(2):148-53.
    View in: PubMed
    Score: 0.020
  7. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
    View in: PubMed
    Score: 0.017
  8. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Pediatr Rheumatol Online J. 2018 Oct 22; 16(1):65.
    View in: PubMed
    Score: 0.017
  9. Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
    View in: PubMed
    Score: 0.017
  10. Malignancy in Pediatric-onset Systemic Lupus Erythematosus. J Rheumatol. 2017 Oct; 44(10):1484-1486.
    View in: PubMed
    Score: 0.016
  11. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis Rheumatol. 2016 10; 68(10):2514-26.
    View in: PubMed
    Score: 0.015
  12. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis. 2014 Mar; 73(3):557-66.
    View in: PubMed
    Score: 0.012
  13. Progressive intracranial fusiform aneurysms and T-cell immunodeficiency. Pediatr Neurol. 2013 Feb; 48(2):130-4.
    View in: PubMed
    Score: 0.011
  14. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum. 2012 Jan; 64(1):285-96.
    View in: PubMed
    Score: 0.011
  15. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus. 2010 Oct; 19(11):1315-25.
    View in: PubMed
    Score: 0.010
  16. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009 May; 60(5):1496-507.
    View in: PubMed
    Score: 0.009
  17. Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediatr. 1989 Jun; 114(6):1055-60.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.